Arid
Lymphoid-like Environment, Which Promotes Proliferation and Induces Resistance to BH3-Mimetics, Is Counteracted By Obinutuzumab in MCL: Biological Rationale for the Oasis Clinical Trial
Chiron, David1,2; Bellanger, Celine1; Papin, Antonin1; Tessoulin, Benoit; Dousset, Christelle1; Maiga, Sophie1; Moreau, Anne3; Esbelin, Julie4; Trichet, Valerie2,5; Chen-Kiang, Selina6; Moreau, Philippe7; Touzeau, Cyrille7,8; Le Gouill, Steven7,8; Amiot, Martine1; Pellat-Deceunynck, Catherine2,9
会议名称58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)
会议日期DEC 03-06, 2016
会议地点San Diego, CA
来源出版物BLOOD
ISSN0006-4971
EISSN1528-0020
出版年2016
卷号128
期号22
出版者AMER SOC HEMATOLOGY
类型Meeting Abstract
语种英语
国家France;USA
收录类别SCI-E ; CPCI-S
WOS记录号WOS:000394446803099
WOS类目Hematology
WOS研究方向Hematology
资源类型会议论文
条目标识符http://119.78.100.177/qdio/handle/2XILL650/305140
作者单位1.Univ Nantes, CNRS, CRCNA, INSERM, Nantes, France;
2.CNRS, GDR3697 Micronit, Nantes, France;
3.Nantes Univ Hosp, Dept Pathol, Nantes, France;
4.CHU, Serv Gynecol & Obster, Nantes, France;
5.Univ Nantes, LPRO, INSERM, Nantes, France;
6.Weill Cornell Med, Meyer Canc Ctr, New York, NY USA;
7.Nantes Univ Hosp, Dept Hematol, Nantes, France;
8.INSERM, UMR892, Nantes, France;
9.INSERM, CNRS, CRCNA, Nantes, France
推荐引用方式
GB/T 7714
Chiron, David,Bellanger, Celine,Papin, Antonin,et al. Lymphoid-like Environment, Which Promotes Proliferation and Induces Resistance to BH3-Mimetics, Is Counteracted By Obinutuzumab in MCL: Biological Rationale for the Oasis Clinical Trial[C]:AMER SOC HEMATOLOGY,2016.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Chiron, David]的文章
[Bellanger, Celine]的文章
[Papin, Antonin]的文章
百度学术
百度学术中相似的文章
[Chiron, David]的文章
[Bellanger, Celine]的文章
[Papin, Antonin]的文章
必应学术
必应学术中相似的文章
[Chiron, David]的文章
[Bellanger, Celine]的文章
[Papin, Antonin]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。